The Lancet Infectious Diseases

According to the findings of the second Access to Medicine Index (ATMI), top pharmaceutical companies are engaging in more initiatives to improve access to medicines and are increasingly cooperative and transparent in sharing such information. Could the world be witnessing a new era in shared social responsibility on access to medicines?